Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

衣壳 生物 计算生物学 转导(生物物理学) 载体(分子生物学) 腺相关病毒 基因组 病毒学 遗传学 基因 病毒 重组DNA 生物化学
作者
Dirk Grimm,Hildegard Büning
出处
期刊:Human Gene Therapy [Mary Ann Liebert, Inc.]
卷期号:28 (11): 1075-1086 被引量:105
标识
DOI:10.1089/hum.2017.172
摘要

Recombinant gene delivery vectors derived from naturally occurring or genetically engineered adeno-associated viruses (AAV) have taken center stage in human gene therapy, fueled by rapidly accumulating and highly encouraging clinical data. Nonetheless, it has also become evident that the current generation of AAV vectors will require improvements in transduction potency, antibody evasion, and cell specificity in order to realize their full potential and to widen applicability in larger patient cohorts. Fortunately, in the recent past, the field has seen a flurry of exciting new developments that enhance our understanding of AAV vector biology, including virus-host interactions, and/or that expand our arsenal of technologies for AAV capsid design and evolution. This review highlights a collection of latest advances in these areas, which, in the authors' opinion, hold particular promise to propel the AAV vector field forward in the near future, especially when applied in combination. These include fundamental novel insights into the AAV life cycle, from an unexpected role of autophagy and interactions with other viruses to the (re-)discovery of a universal AAV receptor and the function of AAV-AAP for capsid assembly. Concurrently, recent successes in the rational design of next-generation synthetic AAV capsids are pointed out, exemplified by the structure-guided derivation of AAV mutants displaying robust in vivo immune evasion. Finally, a variety of new and innovative strategies for high-throughput generation and screening of AAV capsid libraries are briefly reviewed, including Cre recombinase-based selection, ancestral AAV capsid reconstruction, and DNA barcoding of AAV genomes. All of these examples showcase the present momentum in the AAV field and, together with work by many other academic or industrial entities, raise substantial optimism that the remaining hurdles for human gene therapy with AAV vectors will (soon) be overcome.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
沐沐完成签到,获得积分10
1秒前
皮皮发布了新的文献求助10
2秒前
RR完成签到,获得积分10
5秒前
韩hqf发布了新的文献求助10
5秒前
5秒前
xr完成签到,获得积分10
6秒前
黄毅发布了新的文献求助10
6秒前
chiaoyin999应助猪猪hero采纳,获得10
11秒前
丰富雅容完成签到 ,获得积分10
11秒前
cqsuper完成签到,获得积分10
14秒前
王天天完成签到 ,获得积分10
18秒前
轻松笙发布了新的文献求助10
18秒前
摔碎玻璃瓶完成签到,获得积分10
19秒前
jinxuan完成签到,获得积分10
20秒前
20秒前
汉堡包应助gunanshu采纳,获得10
21秒前
22秒前
科研通AI2S应助朱莉采纳,获得10
23秒前
棉花不是花完成签到,获得积分10
26秒前
有终完成签到 ,获得积分10
28秒前
29秒前
科目三应助清风明月采纳,获得10
33秒前
33秒前
白开水完成签到,获得积分10
35秒前
35秒前
静默关注了科研通微信公众号
35秒前
情怀应助肖博文采纳,获得10
36秒前
Hello应助Andy采纳,获得10
37秒前
大成子发布了新的文献求助10
37秒前
奥斯卡发布了新的文献求助10
39秒前
星辰大海应助白开水采纳,获得10
39秒前
清秀的发夹完成签到,获得积分10
39秒前
落后醉易发布了新的文献求助10
40秒前
abc97完成签到,获得积分10
42秒前
顺鑫完成签到 ,获得积分10
43秒前
ldh032应助QR采纳,获得10
45秒前
所所应助QR采纳,获得10
45秒前
ldh032应助候默——辛普森采纳,获得10
45秒前
45秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Mixing the elements of mass customisation 300
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3778058
求助须知:如何正确求助?哪些是违规求助? 3323749
关于积分的说明 10215625
捐赠科研通 3038921
什么是DOI,文献DOI怎么找? 1667711
邀请新用户注册赠送积分活动 798361
科研通“疑难数据库(出版商)”最低求助积分说明 758339